Dr. Reddy's Laboratories Announces Loss of Share Certificates
Dr. Reddy's Laboratories Limited has reported the loss of share certificates. Shareholders have applied for duplicates. A public notice was published on April 23, 2026, in Business Standard and Nava Telangana. Claims must be lodged within 15 days at the Hyderabad office.
The loss of share certificates is a procedural matter that is handled through the issuance of duplicates. It does not have a direct financial impact on the company or its operations. The public notice is a standard compliance requirement.
The announcement is a routine regulatory filing regarding the loss of share certificates and the process for issuing duplicates. It does not contain any financial or operational information that would impact the company's valuation or outlook.
Dr. Reddy's Laboratories Limited has announced the loss or misplacement of certain share certificates. The registered shareholders or their claimants have applied to the company for the issuance of duplicate share certificates. The company has published this notice in the Business Standard and Nava Telangana newspapers on April 23, 2026.
Public caution is advised against dealing with the reported lost share certificates. Any person with a claim regarding these certificates must lodge their claim at the company's registered office at 8-2-337, Road No. 3, Banjara Hills, Hyderabad - 500 034, within 15 days of the notice publication. After this period, no claims will be entertained, and the company will proceed with issuing duplicate share certificates.
The announcement also lists the names of shareholders who have reported lost certificates: Hina Shailendra Zaveri, Shailendra Amrutlal Zaveri, and Surendra Surana. Specific details such as certificate numbers, number of shares, distinctive numbers, and folio numbers are provided for each.
This notice is for the information and records of the stock exchanges and the public.
What to do with a filing like this
Dr. Reddy's Laboratories Limited filed this with the NSE as a statutory disclosure, categorised under loss of share certificate. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Dr. Reddy's Laboratories Limited. Read the original for the full detail.